×
Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.
People also ask
Dec 11, 2020 · The ovarian cancer biomarker CA125 has been investigated thoroughly ... This algorithm incorporates serial changes in CA125 over time rather ...
In a retrospective study of 35 patients with stage III–IV ovarian cancer, the probability to reach a complete (CR) or partial remission (PR) was studied by ...
Sep 15, 2016 · The average time from serum CA125 increase to detection of a recurrent lesion by physical or imaging examination was 122 days.
Jan 20, 2021 · The CA-125 blood test can spot proteins made by ovarian cancer, ... for ovarian cancer and your CA-125 levels go down during this time, ...
Elecsys ® CA 125 II - A biomarker for the management of ovarian cancer patients. ... Is fast with 18 minute assay time; Is available for use in both serum ...
Jul 1, 1993 · At this time, CA125 was a highly significant predictor of survival (P < 0.005), but did not add to performance status (P < 0.001) in ...
Nov 9, 2021 · At this time, there is no at-home test currently available for CA-125 levels. The CA-125 test requires a blood draw in a clinical setting.
These findings have implications for serum CA-125 testing during menses in women with suspected endometriosis, as testing during this time may result in ...
Nov 2, 2020 · Cancer Antigen 125 (CA125) Test · Why Get Tested? To monitor treatment for ovarian cancer or to investigate for a possible ovarian cancer. · When ...